Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital
出版年份 2013 全文链接
标题
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital
作者
关键词
-
出版物
CNS SPECTRUMS
Volume 19, Issue 05, Pages 403-410
出版商
Cambridge University Press (CUP)
发表日期
2013-11-28
DOI
10.1017/s1092852913000874
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nuevas guías para el uso de la polifarmacia antipsicótica
- (2013) Stephen M. Stahl Revista de Psiquiatria y Salud Mental
- Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the ‘real world’
- (2012) N. B. Pai et al. ACTA PSYCHIATRICA SCANDINAVICA
- Antipsychotic polypharmacy: never say never, but never say always
- (2012) Stephen M. Stahl ACTA PSYCHIATRICA SCANDINAVICA
- Clozapine for the treatment of schizophrenia
- (2012) Eric Fakra et al. EXPERT OPINION ON PHARMACOTHERAPY
- Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010
- (2012) Sally V. J. Bowskill et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A systematic review of the evidence of clozapine's anti-aggressive effects
- (2012) Catherine Frogley et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
- (2012) Georges Vauquelin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Clozapine resistance: Augmentation strategies
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia
- (2011) Menahem I. Krakowski et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
- (2011) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
- (2010) MRA Muscatello et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-Term Efficacy and Tolerability of Clozapine Combined with Ziprasidone or Risperidone
- (2010) A. Kuwilsky et al. PHARMACOPSYCHIATRY
- Augmentation of clozapine with a second antipsychotic - a meta-analysis of randomized, placebo-controlled studies
- (2009) D. M. Taylor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
- (2009) Michael Berk et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia
- (2009) Jae Seung Chang et al. JOURNAL OF CLINICAL PSYCHIATRY
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial
- (2008) M Zink et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Amisulpride Augmentation in Patients with Schizophrenia Partially Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) H.-J. Assion et al. PHARMACOPSYCHIATRY
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials
- (2008) C. U. Correll et al. SCHIZOPHRENIA BULLETIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started